CSBR Champions Oncology, Inc. Stock Quote

CSBR [NASD]

Index	-	P/E	1300.00	EPS (ttm)	0.01	Insider Own	20.68%	Shs Outstand	13.40M	Perf Week	1.07%
Market Cap	139.57M	Forward P/E	38.52	EPS next Y	0.27	Insider Trans	0.00%	Shs Float	9.48M	Perf Month	1.46%
Income	0.10M	PEG	86.67	EPS next Q	0.04	Inst Own	50.70%	Short Float	0.75%	Perf Quarter	-1.79%
Sales	42.70M	P/S	3.27	EPS this Y	114.90%	Inst Trans	-7.52%	Short Ratio	1.51	Perf Half Y	-11.04%
Book/sh	0.56	P/B	18.57	EPS next Y	12.50%	ROA	0.40%	Target Price	15.67	Perf Year	11.23%
Cash/sh	0.30	P/C	34.89	EPS next 5Y	15.00%	ROE	1.50%	52W Range	8.09 - 14.68	Perf YTD	-3.61%
Dividend	-	P/FCF	-	EPS past 5Y	15.10%	ROI	3.90%	52W High	-29.16%	Beta	1.14
Dividend %	-	Quick Ratio	1.10	Sales past 5Y	29.70%	Gross Margin	49.70%	52W Low	28.55%	ATR	0.45
Employees	194	Current Ratio	1.10	Sales Q/Q	18.90%	Oper. Margin	0.50%	RSI (14)	51.67	Volatility	2.69% 5.52%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	-343.50%	Profit Margin	0.30%	Rel Volume	0.32	Prev Close	10.46
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Sep 13 AMC	Payout	0.00%	Avg Volume	46.97K	Price	10.40
Recom	2.00	SMA20	0.98%	SMA50	1.04%	SMA200	-2.60%	Volume	14,838	Change	-0.57%

Nov-18-19

Initiated

The Benchmark Company

Speculative Buy

Sep-13-21 04:00PM	Champions Oncology Reports Record Quarterly Revenue of $11.3 Million ACCESSWIRE
Sep-06-21 03:00PM	Champions Oncology, Inc. (CSBR) Reports Next Week: What You Should Expect Zacks
07:09AM	What Kind Of Shareholders Hold The Majority In Champions Oncology, Inc.'s (NASDAQ:CSBR) Shares? Simply Wall St.
Sep-02-21 04:30PM	Champions Oncology to Announce First Quarter Financial Results on Monday, September 13, 2021 ACCESSWIRE
Jul-26-21 08:30AM	Champions Oncology Announces an Expanded Corporate Strategy to Include Drug Discovery and Development ACCESSWIRE
Jul-22-21 08:00AM	Champions Oncology Reports Quarterly Revenue of $10.6 Million ACCESSWIRE
Jul-14-21 08:30AM	Champions Oncology to Announce Fourth Quarter Financial Results on Thursday, July 22, 2021 ACCESSWIRE
Jul-08-21 03:06AM	The Champions Oncology (NASDAQ:CSBR) Share Price Is Up 335% And Shareholders Are Delighted Simply Wall St.
Jun-15-21 09:00AM	Champions Oncology and BGI Americas Announce a Strategic Partnership to Provide Mass Spectrometry Proteomics, Metabolomics, and Multi-Omic Data Analysis Solutions ACCESSWIRE
Apr-29-21 03:31AM	Here's Why We're Not At All Concerned With Champions Oncology's (NASDAQ:CSBR) Cash Burn Situation Simply Wall St. +5.34%
Apr-16-21 12:00PM	Champions Oncology, Inc. (CSBR) Upgraded to Buy: What Does It Mean for the Stock? Zacks
Mar-16-21 10:52AM	Strength Seen in Champions Oncology, Inc. (CSBR): Can Its 15.3% Jump Turn into More Strength? Zacks
Mar-15-21 02:13AM	What Type Of Shareholders Own The Most Number of Champions Oncology, Inc. (NASDAQ:CSBR) Shares? Simply Wall St. +15.31%
Mar-11-21 04:00PM	Champions Oncology Reports Record Quarterly Revenue of $10.8 Million ACCESSWIRE
02:30PM	Champions Oncology, Inc. to Host Earnings Call ACCESSWIRE
Mar-05-21 08:30AM	Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 11, 2021 ACCESSWIRE
Mar-04-21 12:30PM	Analysts Estimate Champions Oncology, Inc. (CSBR) to Report a Decline in Earnings: What to Look Out for Zacks
Feb-22-21 09:00AM	Champions Oncology Announces Addition to Board of Directors ACCESSWIRE
Jan-29-21 12:24AM	Can You Imagine How Jubilant Champions Oncology's (NASDAQ:CSBR) Shareholders Feel About Its 220% Share Price Gain? Simply Wall St.
Jan-19-21 09:00AM	Champions Oncology Announces Partnership with Code Ocean to Expand the Functionality of Lumin Bioinformatics ACCESSWIRE
Jan-05-21 08:30AM	Champions Oncology Announces the Expansion of Lumin Bioinformatics: Now Featuring a Highly Valuable Set of Proteomic Data and Analytics ACCESSWIRE
Dec-15-20 12:22AM	Are Investors Undervaluing Champions Oncology, Inc. (NASDAQ:CSBR) By 25%? Simply Wall St.
Dec-14-20 04:00PM	Champions Oncology Reports Record Quarterly Revenue of $10.1 Million ACCESSWIRE
Dec-07-20 04:00PM	Champions Oncology to Announce Second Quarter Financial Results on Monday, December 14, 2020 ACCESSWIRE
Nov-16-20 04:40PM	Champions Oncology Announces the Launch of Lumin Bioinformatics, Its New Oncology Data-Driven SaaS Program ACCESSWIRE +14.94%
Nov-11-20 09:00AM	Champions Oncology Expands Its Immuno-Oncology Research Offering by Launching a Unique Autologous Tumor Infiltrating Lymphocyte Ex Vivo Platform ACCESSWIRE
Oct-31-20 10:08AM	Should You Investigate Champions Oncology, Inc. (NASDAQ:CSBR) At US$8.78? Simply Wall St.
Sep-16-20 07:27AM	Champions Oncology, Inc. Just Beat Revenue Estimates By 11% Simply Wall St.
Sep-14-20 04:00PM	Champions Oncology Reports Record Quarterly Revenue of $9.5 Million ACCESSWIRE
Sep-08-20 04:30PM	Champions Oncology to Announce First Quarter Financial Results on Monday, September 14, 2020 ACCESSWIRE -9.35%
Jul-30-20 07:21AM	Champions Oncology, Inc. Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts Simply Wall St.
Jul-27-20 04:01PM	Champions Oncology Reports Quarterly Revenue of $8.8 Million ACCESSWIRE
Jul-22-20 08:00AM	Champions Oncology to Announce Fourth Quarter Financial Results on Monday, July 27, 2020 ACCESSWIRE +6.75%
Jul-15-20 03:55PM	What Type Of Shareholders Own The Most Number of Champions Oncology, Inc. (NASDAQ:CSBR) Shares? Simply Wall St.
Jun-17-20 09:37AM	The Truth About Market Timing - June 17, 2020 Zacks
May-27-20 07:05AM	If You Had Bought Champions Oncology (NASDAQ:CSBR) Shares Three Years Ago You'd Have Made 278% Simply Wall St.
Apr-28-20 09:50AM	Timing the Market, Is it Possible? - April 28, 2020 Zacks
Apr-27-20 07:20AM	Is Champions Oncology, Inc. (NASDAQ:CSBR) A Volatile Stock? Simply Wall St.
Mar-28-20 09:23AM	Companies Like Champions Oncology (NASDAQ:CSBR) Can Afford To Invest In Growth Simply Wall St.
Mar-16-20 09:35AM	When Does Market Timing Actually Work? - March 16, 2020 Zacks -14.49%
Mar-12-20 04:17PM	Champions Oncology Reports Record Quarterly Revenue of $9.0 Million ACCESSWIRE -12.71%
Mar-10-20 08:30AM	Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 12, 2020 ACCESSWIRE -6.49%
Feb-26-20 09:32AM	Timing the Market, Is it Possible? - February 26, 2020 Zacks
Feb-18-20 05:44AM	Does Champions Oncology, Inc.'s (NASDAQ:CSBR) CEO Pay Reflect Performance? Simply Wall St.
Feb-05-20 09:23AM	When Does Market Timing Actually Work? - February 05, 2020 Zacks
Jan-29-20 09:00AM	The Children's Cancer Therapy Development Institute is collaborating with Champions Oncology and The Jackson Laboratory to provide RACE Act/PREA pediatric cancer study plan services ACCESSWIRE
Jan-17-20 09:34AM	How to Time the Markets Like an Investing Pro - January 17, 2020 Zacks
Jan-13-20 06:07AM	Is There An Opportunity With Champions Oncology, Inc.'s (NASDAQ:CSBR) 42% Undervaluation? Simply Wall St.
Dec-24-19 09:37AM	The Market Timing Secrets No One Talks About - December 24, 2019 Zacks
Dec-16-19 04:00PM	Champions Oncology Reports Quarterly Revenue of $7.6 Million ACCESSWIRE +12.08%
Dec-09-19 08:30AM	Champions Oncology to Announce Second Quarter Financial Results on Monday, December 16, 2019 ACCESSWIRE
Dec-08-19 08:59AM	Investors Who Bought Champions Oncology (NASDAQ:CSBR) Shares Three Years Ago Are Now Up 231% Simply Wall St.
Dec-04-19 08:36AM	Simple Market Timing Strategies That Work - December 04, 2019 Zacks +6.54%
Nov-14-19 08:53AM	The Truth About Market Timing - November 14, 2019 Zacks
Nov-13-19 05:00PM	Champions Oncology and PhenoVista Biosciences Announce a Strategic Partnership to provide Oncology Imaging-based Phenotypic Assays for Preclinical Drug Development ACCESSWIRE -5.90%
Nov-12-19 07:27AM	What Kind Of Shareholders Own Champions Oncology, Inc. (NASDAQ:CSBR)? Simply Wall St.
Oct-24-19 09:00AM	The Truth About Market Timing - October 24, 2019 Zacks
Oct-18-19 07:41AM	We Think Champions Oncology (NASDAQ:CSBR) Can Easily Afford To Drive Business Growth Simply Wall St.
Oct-03-19 08:49AM	When Does Market Timing Actually Work? - October 03, 2019 Zacks +5.22%
Sep-25-19 12:43PM	What Does Champions Oncology, Inc.'s (NASDAQ:CSBR) Share Price Indicate? Simply Wall St.
Sep-16-19 04:00PM	Champions Oncology Reports Quarterly Revenue of $6.7 Million ACCESSWIRE +14.05%
02:30PM	Champions Oncology, Inc. to Host Earnings Call ACCESSWIRE
Sep-13-19 08:39AM	The Truth About Market Timing - September 13, 2019 Zacks
Sep-09-19 08:30AM	Champions Oncology to Announce First Quarter Financial Results on Monday, September 16, 2019 ACCESSWIRE
Sep-02-19 01:30PM	How Much is Champions Oncology, Inc.'s (NASDAQ:CSBR) CEO Getting Paid? Simply Wall St.
Aug-26-19 08:37AM	Yes, You Can Time the Market. Find out How - August 26, 2019 Zacks +5.04%
Aug-05-19 08:42AM	Simple Market Timing Strategies That Work - August 05, 2019 Zacks -7.04%
Jul-29-19 06:48PM	Champions Oncology Inc (CSBR) Files 10-K for the Fiscal Year Ended on April 30, 2019 GuruFocus.com
Jul-26-19 06:58AM	Champions Oncology, Inc. (NASDAQ:CSBR) Delivered A Weaker ROE Than Its Industry Simply Wall St.
Jul-15-19 04:35PM	Champions Oncology Reports Record Quarterly Revenue of $7.7 Million For The Fourth Quarter Ended April 30, 2019 ACCESSWIRE +12.94%
Jul-12-19 10:00AM	Champions Oncology to Announce Fourth Quarter Financial Results on Monday, July 15, 2019 ACCESSWIRE
Jul-02-19 09:35AM	Calculating The Intrinsic Value Of Champions Oncology, Inc. (NASDAQ:CSBR) Simply Wall St.
May-31-19 09:37AM	How Many Champions Oncology, Inc. (NASDAQ:CSBR) Shares Have Insiders Sold, In The Last Year? Simply Wall St.
May-30-19 08:30AM	Champions Oncology Partners with TransCure bioServices to Expand European Business and Operations ACCESSWIRE
May-01-19 08:07AM	What Kind Of Shareholder Owns Most Champions Oncology, Inc. (NASDAQ:CSBR) Stock? Simply Wall St. -5.07%
Apr-17-19 09:49AM	Moving Average Crossover Alert: Champions Oncology Zacks -8.08%
Apr-16-19 10:51AM	New Strong Sell Stocks for April 16th Zacks
Apr-01-19 08:54AM	New Strong Sell Stocks for April 1st Zacks -7.35%
Mar-27-19 10:03AM	New Strong Sell Stocks for March 27th Zacks
Mar-25-19 10:42AM	New Strong Sell Stocks for March 25th Zacks
Mar-18-19 04:00PM	Champions Oncology Reports Quarterly Revenue of $6.4 Million ACCESSWIRE
Mar-06-19 08:30AM	Champions Oncology to Announce Third Quarter Financial Results on Monday, March 18, 2019 ACCESSWIRE
Mar-04-19 11:40PM	Champions Oncology (CSBR) Q3 Earnings: What's in Store? Zacks -6.39%
Jan-10-19 08:43AM	Weakness Seen in Champions Oncology (CSBR) Estimates: Should You Stay Away? Zacks
Dec-17-18 03:30PM	Champions Oncology Participates in Pre-Clinical Studies to Identify Novel Therapy for Childhood Cancer ACCESSWIRE
03:00PM	Champions Oncology Reports Quarterly Revenue of $6.7 Million ACCESSWIRE
Dec-10-18 04:30PM	Champions Oncology to Announce Second Quarter Financial Results on Monday, December 17, 2018 PR Newswire
Nov-22-18 05:45PM	Champions Oncology (CSBR) Outpaces Stock Market Gains: What You Should Know Zacks
Nov-16-18 05:45PM	Champions Oncology (CSBR) Stock Sinks As Market Gains: What You Should Know Zacks
Nov-15-18 07:20AM	Analysis: Positioning to Benefit within Red Lion Hotels, P.A.M. Transportation Services, Champions Oncology, Kingstone Companies, Applied DNA Sciences, and Innodata Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Nov-07-18 08:30AM	Champions Oncology to Participate in the 9th Annual Craig-Hallum Alpha Select Conference PR Newswire
Nov-05-18 05:45PM	Champions Oncology (CSBR) Outpaces Stock Market Gains: What You Should Know Zacks
Nov-02-18 07:27AM	Champions Oncology Sees Hammer Chart Pattern: Time to Buy? Zacks
Oct-29-18 09:30AM	Has Champions Oncology (CSBR) Outpaced Other Medical Stocks This Year? Zacks
Oct-23-18 05:45PM	Champions Oncology (CSBR) Gains As Market Dips: What You Should Know Zacks
Oct-12-18 09:30AM	Has Champions Oncology (CSBR) Outpaced Other Medical Stocks This Year? Zacks
Oct-04-18 06:55AM	Bull Of The Day: Champions Oncology (CSBR) Zacks
Oct-01-18 12:10PM	Best ETFs & Stocks From the Top Sector of Q3 Zacks
Sep-28-18 09:15AM	Tech Breaks S&P Out of Slump Zacks
Sep-21-18 10:00AM	Looking for a Top Momentum Pick? Why Champions Oncology (CSBR) is a Great Choice Zacks

Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides Personalized Oncology Solutions (POS) that assist physicians in developing personalized treatment options for cancer patients through tumor specific data obtained from drug panels and related personalized oncology services. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, the company provides POS products, including TumorGraft implants and drug panels, which utilizes TumorGraft technology to test the response of a patient's tumor to multiple oncology drugs or drug combinations. It markets its products through internet, word of mouth, and sales force to patients and physicians. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Breitfeld Philip P.	Director	Mar 23	Option Exercise	3.65	4,167	15,210	4,167	Mar 25 03:27 PM
Poliakoff Abba David	Director	Jan 19	Option Exercise	3.41	30,000	102,300	90,147	Feb 08 04:46 PM
Breitfeld Philip P.	Director	Dec 16	Sale	11.35	31,443	356,976	0	Dec 17 09:29 AM
TOBIN SCOTT R	Director	Oct 30	Option Exercise	5.46	10,000	54,600	10,000	Oct 30 04:36 PM
SIDRANSKY DAVID	Director	Oct 16	Option Exercise	5.46	16,667	91,002	758,334	Oct 28 02:53 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience